Company
Headquarters: Shijiazhuang, China
Employees: 10,909
CN¥9.26 Billion
CNY as of Jan. 1, 2025
US$1.27 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
North China Pharmaceutical Company Ltd. operates as a chemical pharmaceutical company in China. It primarily offers anti-infective drugs, comprising APIs, and intermediates and their preparations; biotechnology drugs; cardiovascular and immunomodulators; vitamins health consumer products; and bio-agricultural and veterinary drugs. North China Pharmaceutical Company Ltd. was founded in 1953 and is based in Shijiazhuang, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥9.71 B |
| EBITDA | CN¥674.2 M |
| Gross Profit TTM | CN¥2.97 B |
| Profit Margin | 0.82% |
| Operating Margin | 7.68% |
| Quarterly Revenue Growth | -15.00% |
North China Pharmaceutical Company Ltd has the following listings and related stock indices.
Stock: SSE: 600812 wb_incandescent